Skip to content

Polypharmacy in maintenance hemodialysis patients: Prevalence, correlates, and association with nursing-sensitive outcomes

Polypharmacy in maintenance hemodialysis patients: Prevalence, correlates, and association with nursing-sensitive outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128247
Enrollment
Unknown
Registered
2026-07-16
Start date
2026-07-21
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney disease

Interventions

Non-polypharmacy group:None
Polypharmacy group:None

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clear disease diagnosis: Meets the diagnostic criteria for stage 5 chronic kidney disease (end-stage renal disease) in the Guidelines for Screening, Diagnosis and Prevention of Chronic Kidney Disease (2022 Edition), with estimated glomerular filtration rate (eGFR) < 15 ml/(min·1.73 m^2); 2. Adequate dialysis status: Receives regular maintenance hemodialysis treatment at the hospital's blood purification center, with a dialysis frequency of 3 times per week.

Exclusion criteria

Exclusion criteria: Relevant clinical data is missing.

Design outcomes

Primary

MeasureTime frame
All-cause mortality rate;Unplanned readmission rate;

Secondary

MeasureTime frame
Nosocomial infection incidence rate;Adverse drug reaction incidence rate;Cardiovascular event incidence rate;Severe electrolyte disorder incidence rate;Fall incidence rate;

Countries

China

Contacts

Public ContactLiu Hang

The First Affiliated Hospital of Army Medical University, PLA

1101396261@qq.com+86 23 6876 5373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026